Influence of cross-linking agent type and chitosan content on the performance of pectinate-chitosan beads aimed for colon-specific drug delivery

References

• Yang L, Chu JS, Fix JA. (2002). Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm, 235:1–15.
   PubMed Web of Science ®Google Scholar
• Van den Mooter G. (2006). Colon drug delivery. Expert Opin Drug Deliv, 3:111–125.
   PubMedGoogle Scholar
• Jain SK, Jain A. (2008). Target-specific drug release to the colon. Expert Opin Drug Deliv, 5:483–498.
   PubMed Web of Science ®Google Scholar
• Ashford M, Fell JT, Attwood D, Woodhead P. (1993). An in vitro investigation into the suitability of pH-dependent polymers for colonic targeting. Int J Pharm, 91:241–245.
   Web of Science ®Google Scholar
• Liu L, Fishman ML, Kost J, Hicks KB. (2003). Pectin-based systems for colon-specific drug delivery via oral route. Biomaterials, 24:3333–3343.
   PubMed Web of Science ®Google Scholar
• Basit AW. (2005). Advances in colonic drug delivery. Drugs, 65:1991–2007.
   PubMed Web of Science ®Google Scholar
• Singh BN. (2007). Modified-release solid formulations for colonic delivery. Recent Pat Drug Deliv Formul, 1:53–63.
   PubMedGoogle Scholar
• Sinha VR, Kumria R. (2001). Polysaccharides in colon-specific drug delivery. Int J Pharm, 224:19–38.
   PubMed Web of Science ®Google Scholar
• Vandamme TF, Lenourry A, Charrueau C, Chaumeil JC. (2002). The use of polysaccharides to target drugs to the colon. Carbohydr Polym, 48:219–231.
   Web of Science ®Google Scholar
• Friend DR. (2005). New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Deliv Rev, 57:247–265.
   PubMed Web of Science ®Google Scholar
• Mura P, Maestrelli F, Cirri M, González Rodríguez ML, Rabasco Alvarez AM. (2003). Development of enteric-coated pectin-based matrix tablets for colonic delivery of theophylline. J Drug Target, 11:365–371.
   PubMed Web of Science ®Google Scholar
• Maestrelli F, Cirri M, Corti G, Mennini N, Mura P. (2008a). Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery. Eur J Pharm Biopharm, 69:508–518.
   PubMed Web of Science ®Google Scholar
• Rubinstein A, Radaï R. (1995). In vitro and in vivo analysis of colon specificity of calcium pectinate formulations. Eur J Pharm Biopharm, 41:291–295.
   Web of Science ®Google Scholar
• Sriamornsak P, Nunthanid J. (1998). Calcium pectinate gel beads for controlled release drug delivery: I. Preparation and in vitro release studies. Int J Pharm, 160:207–212.
   Web of Science ®Google Scholar
• El-Gibaly I. (2002). Oral delayed-release system based on Zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcium pectinate beads for colonic drug delivery. Int J Pharm, 232:199–211.
   PubMed Web of Science ®Google Scholar
• Chambin O, Dupuis G, Champion D, Voilley A, Pourcelot Y. (2006). Colon-specific drug delivery: Influence of solution reticulation properties upon pectin beads performance. Int J Pharm, 321:86–93.
   PubMed Web of Science ®Google Scholar
• Dupuis G, Chambin O, Génelot C, Champion D, Pourcelot Y. (2006). Colonic drug delivery: influence of cross-linking agent on pectin beads properties and role of the shell capsule type. Drug Dev Ind Pharm, 32:847–855.
   PubMed Web of Science ®Google Scholar
• Das S, Ng KY, Ho PC. (2010). Formulation and optimization of zinc-pectinate beads for the controlled delivery of resveratrol. AAPS PharmSciTech, 11:729–742.
   PubMed Web of Science ®Google Scholar
• Illum L. (1998). Chitosan and its use as a pharmaceutical excipient. Pharm Res, 15:1326–1331.
   PubMed Web of Science ®Google Scholar
• Paul W, Sharma CP. (2000). Chitosan, a drug carrier for the 21th century. STP Pharma Sci, 10:5–22.
   Google Scholar
• Asane GS, Nirmal SA, Rasal KB, Naik AA, Mahadik MS, Rao YM. (2008). Polymers for mucoadhesive drug delivery system: a current status. Drug Dev Ind Pharm, 34:1246–1266.
   PubMed Web of Science ®Google Scholar
• Marudova M, MacDougall AJ, Ring SG. (2004). Pectin-chitosan interactions and gel formation. Carbohydr Res, 339:1933–1939.
   PubMed Web of Science ®Google Scholar
• Marudova M, Lang S, Brownsey GJ, Ring SG. (2005). Pectin-chitosan multilayer formation. Carbohydr Res, 340:2144–2149.
   PubMed Web of Science ®Google Scholar
• Fernández-Hervás MJ, Fell JT. (1998). Pectin/chitosan mixtures as coating for colon-specific drug delivery: an in vitro evaluation. Int J Pharm 169:115–119.
   Web of Science ®Google Scholar
• Munjeri O, Collett JH, Fell JT. (1997). Hydrogel beads based on amidated pectins for colon-specific drug delivery: the role of chitosan in modifying drug release. J Control Release, 46:273–278.
   Web of Science ®Google Scholar
• Chang KLB, Lin J. (2000). Swelling behavior and the release of protein from chitosan–pectin composite particles. Carbohydrate Polym, 43:163–169.
   Web of Science ®Google Scholar
• Atyabi F, Majzoob S, Iman M, Salehi M, Dorkoosh F. (2005). In vitro evaluation and modification of pectinate gel beads containing trimethyl chitosan as a multi-particulate system for delivery of water-soluble macromolecules to colon. Carbohydrate Polym, 61:39–51.
   Web of Science ®Google Scholar
• Maestrelli F, Zerrouk N, Cirri M, Mennini N, Mura P. (2008b). Microspheres for colonic delivery of ketoprofen-hydroxypropyl-beta-cyclodextrin complex. Eur J Pharm Sci, 34:1–11.
   PubMed Web of Science ®Google Scholar
• Krämer J, Bl Leeuw BJ, Lueßen HL, de Boer AG, Verhoef JC, Junginger HE. (1997). Chitosans for enhanced delivery of therapeutics peptides across intesume H. (1994). Biopharmaceutical aspects of multiparticulates. In: Y. Ghebre-Sellasie, ed. Multiparticulate Oral Drug Delivery. New York: Marcel Dekker, 307–332.
   Google Scholar
• Roy P, Shahiwala A. (2009). Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. J Control Release, 134:74–80.
   PubMed Web of Science ®Google Scholar
• Rodríguez M, Vila-Jato JL, Torres D. (1998). Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release, 55:67–77.
   PubMed Web of Science ®Google Scholar
• Kharenko EA, Larionova NI, Demina NB. (2009). Mucoadhesive drug delivery systems. Pharm Chem J, 43:200–208.
   Web of Science ®Google Scholar
• Mennini N, Furlanetto S, Maestrelli F, Pinzauti S, Mura P. (2008). Response surface methodology in the optimization of chitosan-Ca pectinate bead formulations. Eur J Pharm Sci, 35:318–325.
   PubMed Web of Science ®Google Scholar
• Das S, Chaudhury A, Ng KY. (2011). Preparation and evaluation of zinc-pectin-chitosan composite particles for drug delivery to the colon: role of chitosan in modifying in vitro and in vivo drug release. Int J Pharm, 406:11–20.
   PubMed Web of Science ®Google Scholar
• Hagesaether E, Hiorth M, Sande SA. (2009). Mucoadhesion and drug permeability of free mixed films of pectin and chitosan: an in vitro and ex vivo study. Eur J Pharm Biopharm, 71:325–331.
   PubMed Web of Science ®Google Scholar
• Hagesaether E, Bye R, Sande SA. (2008). Ex vivo mucoadhesion of different zinc-pectinate hydrogel beads. Int J Pharm, 347:9–15.
   PubMed Web of Science ®Google Scholar
• Kotzè AF, detinal epithelia: in vitro evaluation in Caco-2 cell monolayers. Int J Pharm, 159:243–253.
   Google Scholar
• González-Rodríguez ML, Maestrelli F, Mura P, Rabasco AM. (2003). In vitro release of sodium diclofenac from a central core matrix tablet aimed for colonic drug delivery. Eur J Pharm Sci, 20:125–131.
   PubMed Web of Science ®Google Scholar
• Moffat O, Widdop A. (2004). Clarke’s analysis of drug and poison, 3rd Ed. London, UK: Pharmaceutical Press.
   Google Scholar
• Sriamornsak P, Thirawong N. (2003). Use of back-scattered electron imaging as a tool for examining matrix structure of calcium pectinate. Int J Pharm, 267:151–156.
   PubMed Web of Science ®Google Scholar
• Thanou M, Verhoef JC, Junginger HE. (2001). Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev, 50 Suppl 1:S91–101.
   PubMed Web of Science ®Google Scholar
• Ahuja A, Khar RK, Ali J. (1997). Mucoadhesive drug delivery systems. Drug Dev Ind Pharm, 23:489–515.
   Web of Science ®Google Scholar
• Raiman J, Törmälehto S, Yritys K, Junginger HE, Mönkkönen J. (2003). Effects of various absorption enhancers on transport of clodronate through Caco-2 cells. Int J Pharm, 261:129–136.
   PubMed Web of Science ®Google Scholar
• Sakai M, Imai T, Ohtake H, Azuma H, Otagiri M. (1998). Effects of absorption enhancers on cytoskeletal actin filaments in Caco-2 cell monolayers. Life Sci, 63:45–54.
   Google Scholar